Merus - 53 Year Dividend History | MRUS
Historical dividend payout and yield for Merus (MRUS) since 1971. The current TTM dividend payout for Merus (MRUS) as of April 17, 2024 is $0.00. The current dividend yield for Merus as of April 17, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.366B |
$0.044B |
|
Merus B.V. is a clinical-stage immuno-oncology company developing bispecific antibody therapeutics, referred to as Biclonics. The company's bispecific antibody candidate, MCLA-128, is being evaluated in a Phase 1/2 clinical trial as a potential treatment for HER2-expressing solid tumors; MCLA-117, is being developed as a potential treatment for acute myeloid leukemia and MCLA-158, which is designed to bind to cancer stem cells and is being developed as a potential treatment for colorectal cancer and other solid tumors. Merus B.V. is headquartered in Utrecht, the Netherlands.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
